At Quibim, we design pioneering tools that unlock imaging data to improve patient outcomes. Our main purpose is the application of AI techniques to medical images from MRI, CT, PET to unlock new data which can be transformed into actionable predictions for life sciences and providers.

Horizon 2020

EASME - EU Executive Agency for SMEs

Angels Capital

Tech Transfer UPV

Crista Galli Ventures

Partech

Adara Ventures

Amadeus Capital Partners

APEX Ventures

Quibim

🔴 Did you miss our latest webinar? If you skipped our latest conversation on the intersection of #AI and radiomics in biopharma, don't worry! The recording is now available so you can catch up on all the discussions and innovative ideas shared by our top-notch speakers.
 
💻  Ideal for researchers, scientists, and professionals in the biopharmaceutical, technology, and medical fields looking to stay current in this rapidly changing landscape, the transformative impact of AI was highlighted through case studies and success stories shared by our panel of experts.

Take advantage of this chance to access the valuable insights shared during the live event! https://bit.ly/47S8v6b 

Pamod Hemakumara
Fuensanta Bellvís Bataller
Ronald Korn

❄ We recently attended the 'Journées d'Hiver de la Société d'Imagerie Génito-Urinaire (SIGU) 2024', organized by the Société Française de Radiologie et d'imagerie médicale (SFR).

It was amazing to interact with the French Genito-Urinary Imaging Society, exchanging views, and collaborating with subject matter experts, we showcased our cutting-edge imaging and #prostate solutions.

Special thanks to Philippe PUECH, Raphaële Renard Penna , carole delerue and Patricia Gutierrez for their organization. Stay tuned for updates from this event in the heart of the French Alps!

#MedicalImaging #PrecisionHealth

Exciting news! We are proud to announce our strategic collaboration with Merck KGaA, Darmstadt, Germany to advance #PrecisionMedicine through AI-powered radiomics solutions.

🌍 Global challenge: Efficient clinical development for #cancer is a critical challenge globally, given the increasing number of patients needing personalized treatment. According to the Global Cancer Observatory, with cancer cases expected to reach 30 million new cases each year by 2040, our mission is to reduce costs and timelines in drug development programs.
 
🎯 Precise solution: Our #AI expertise creates predictive models, optimizing patient stratification and characterization and understanding the potential benefits of novel therapies. Merck intends to integrate these models into its global drug development and commercialization strategies, fostering #data-driven decision-making.
 
Read everything about it https://bit.ly/3OioIdQ and stay tuned for updates as we further transform #cancercare.

🚀 At the vanguard of innovation our CEO, Dr.Ángel Alberich-Bayarri, participated this morning in the latest #TechTrends 2024, organized by Globant and Business Insider España. The conference has delved into fundamental and relevant topics such as #AI or quantum computing, areas that are changing industries and driving transformational changes.
 
Discussions like this truly underscore our commitment to staying ahead of the curve, embracing emerging technologies and contributing to the global dialogue on #innovation. It was a great opportunity to network with thought leaders, industry experts and visionaries conducting change in the technology landscape.

Enlitic focuses on healthcare data management, particularly in radiology, offering solutions that standardize, protect, integrate, and analyze medical imaging data using artificial intelligence.

Enlitic

Quantib is a competitor of Quibim in the field of medical imaging analysis, providing quantitative radiology solutions for healthcare professionals, researchers, and pharmaceutical companies.

Quantib

Arterys, formerly known as Morpheus Medical, Inc., is a company founded in 2011 and based in San Francisco, California. It focuses on transforming medical imaging for precision health within the life sciences sector.

Arterys

Aidoc is a competitor of Quibim in the field of medical imaging analysis, providing solutions that leverage artificial intelligence to assist radiologists in detecting abnormalities in medical images.

Aidoc

Quibim is a company that designs pioneering tools to unlock imaging data and improve patient outcomes. They apply AI techniques to medical images from MRI, CT, PET to create actionable predictions for life sciences and providers.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 5, 2024 5:30 AM	8bec4476
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 5, 2024 5:30 AM	c1cc0a11
company summary	general
signals	general
crunchbase trigger	general	Oct 31, 2024 9:55 AM	a1c2a491
crunchbase profile	general
li profile	general	Mar 5, 2024 5:30 AM	8c458923
translate crunchbase fundingrounds	general
peers	general
news basic	general	Mar 5, 2024 5:30 AM	a4259e8d
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:QUIBIM

Quibim